NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Dixon Technologies (India) Shares Fall 3% Amid Morgan Stanley's 'Underweight' Rating

Shares of Dixon Technologies (India) declined by more than 3% on Friday, reaching an intraday low of Rs 10,645 per share on the NSE. This marks the fifth consecutive session of decline and a cumulative drop of more than 9% in the period. The stock's performance is attributed to Morgan Stanley maintaining its 'Underweight' rating on the stock, with a price target of Rs 8,157 per share.

The cautious view by Morgan Stanley comes amidst a sharp rise in Dynamic Random Access Memory (DRAM) prices. As of February 13, 2026, DRAM spot prices have increased 6.8 times year-on-year. Average mobile DRAM prices for LPDDR4 and LPDDR5 have risen 55% and 64% quarter-on-quarter, respectively. According to TrendForce, mobile DRAM prices are expected to surge 88-93% in Q1CY26 and a further 20-25% in Q2CY26.

Morgan Stanley has pointed out that nearly 75% of India's smartphone market is priced below USD 300, making it sensitive to component cost inflation. Higher DRAM prices could pose an incremental headwind for an industry already witnessing muted demand trends.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Other stocks in the sector, such as Kaynes Technology India Ltd and PG Electroplast Ltd, also declined. Kaynes Technology India fell 1.15% to Rs 3,826.20 per share, while PG Electroplast was down 1.64% at Rs 604.15 per share.

Investor Takeaway

Investors should be cautious of Dixon Technologies (India) stock due to the maintained 'Underweight' rating and potential rise in DRAM prices.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.